Cancer Research UK logo.
SearchDonate
  • Search

A trial of cabozantinib after chemotherapy for sarcoma of the womb that has spread or can’t be removed with an operation (HGUtS study)

Overview

Cancer types:

Sarcoma, Soft tissue sarcoma, Womb (uterine or endometrial) cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is for women with rare types of high grade sarcoma of the womb.

Cancer Research UK supports this trial.

Recruitment start: 23 February 2016

Recruitment end: 30 June 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Helen Hatcher

Supported by

Cancer Research UK

Exelixis

Experimental Cancer Medicine Centre (ECMC)

European Organisation for Research and Treatment of Cancer (EORTC)

International Rare Cancer Initiative (IRCI)

NHS Greater Glasgow and Clyde

Other information

This is Cancer Research UK trial number CRUK/13/020.

Last reviewed: 18 December 2023

CRUK internal database number: 11734

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.